Education
About Us
Working with TipRanks
Follow Us
Immucell Corp. (ICCC)
NASDAQ:ICCC
Total Valuation
Immucell has a market cap or net worth of $45.50M. The enterprise value is $57.36M.
Market Cap$45.50M
Enterprise Value$57.36M
Share Statistics
Immucell has 8.98M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8.98M
Owened by Insiders1.55%
Owened by Instutions4.27%
Financial Efficiency
Immucell’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is 0.04%.
Return on Equity (ROE)-8.17%
Return on Assets (ROA)0.00%
Return on Invested Capital (ROIC)0.04%
Return on Capital Employed (ROCE)0.04%
Revenue Per Employee$383,957.101
Profits Per Employee-$31,249.043
Employee Count69
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Immucell is -19.50. Immucell’s PEG ratio is 0.30.
PE Ratio-19.50
PS Ratio1.59
PB Ratio1.59
Price to Fair Value1.59
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.30
Income Statement
In the last 12 months, Immucell had revenue of $26.49M and earned -$2.16M in profits. Earnings per share was -$0.29.
Revenue$26.49M
Gross Profit$7.94M
Operating Income-$575.96M
Pretax Income-$2.15M
Net Income-$2.16M
EBITDA-573.94M
Earnings Per Share (EPS)-0.29
Cash Flow
In the last 12 months, operating cash flow was $360.95K and capital expenditures -$269.51K, giving a free cash flow of $91.44K billion.
Operating Cash Flow$360.95K
Free Cash Flow$91.44K
Free Cash Flow per Share$0.01
Dividends & Yields
Immucell pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield0.00%
Earnings Yield-5.13%
Stock Price Statistics
Beta-0.02
52-Week Price Change7.77%
50-Day Moving Average5.08
200-Day Moving Average4.36
Relative Strength Index (RSI)43.53
Average Volume (3m)18.16K
Important Dates
Immucell upcoming earnings date is May 14, 2025, After Close.
Last Earnings DateFeb 25, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Immucell as a current ratio of <0.01, with Debt / Equity ratio of 0.00
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Immucell has paid $1.35M in taxes.
Income Tax$1.35M
Effective Tax Rate-0.47%
Enterprise Valuation
Immucell EV to EBITDA ratio is 40.27, with an EV/FCF ratio of 0.00.
EV to Sales1.59
EV to EBITDA40.27
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Immucell has $3.81M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$3.81M billion.
Cash & Marketable Securities$3.81M
Total Debt$0.00
Net Cash-$3.81M
Net Cash Per Share-$0.42
Tangible Book Value Per Share-$1.61K
Margins
Gross margin is 29.97%, with operating margin of -6.19%, and net profit margin of -8.14%.
Gross Margin29.97%
Operating Margin-6.19%
Pretax Margin-8.10%
Net Profit Margin-8.14%
EBITDA Margin3.94%
EBIT Margin-6.19%
Analyst Forecast
The average price target for Immucell is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast51.63%
EPS Growth Forecast62.32%